Wei Chen

陳偉
CE No. BNU878 Active

This page summarises the Hong Kong Securities and Futures Commission (SFC) public register record for Wei Chen (陳偉), a licensed Representative with CE reference BNU878. Currently licensed at 1 firm(s): Aspex Management (HK) Limited. Active regulated activities: Type 9 - Asset management. This person has 7.6 years of SFC licence history. Total licence records on file: 1.

Information

LinkedIn:
Email:

Licence history

FirmRoleRegulated activityFromTo
Aspex Management (HK) Limited
Rep Type 9 - Asset management 2018-11-22 present

Worked alongside

The 20 closest colleagues, strongest tie first — individuals licensed at the same firm as Wei Chen during overlapping periods. Ranked by how long they overlapped and how similar their regulated activities were, with shared time at a smaller firm weighted more than at a large one. See the detailed formula.

NameShared firmOverlap
Ho Kei Li Aspex Management (HK) Limited 2018–present
Chun Yai Wang Aspex Management (HK) Limited 2018–present
David Jinsig Lee Aspex Management (HK) Limited 2018–present
Pok Him Wong Aspex Management (HK) Limited 2018–present
Bonnie Shin Tsing Fong Aspex Management (HK) Limited 2019–present
Atsushi Sakano Aspex Management (HK) Limited 2018–2025
Jinrong Andy Wong Aspex Management (HK) Limited 2020–present
Gaoxiang Liu Aspex Management (HK) Limited 2021–present
Vanessa Ho Shan Chow Aspex Management (HK) Limited 2021–present
Alan Chi Hang Kwong Aspex Management (HK) Limited 2021–present
Chung Wa Yu Aspex Management (HK) Limited 2022–present
John Patrick Harris Aspex Management (HK) Limited 2022–present
Junying Peng Aspex Management (HK) Limited 2021–2025
Tiancong Wang Aspex Management (HK) Limited 2022–2025
Gaurav Jagdish Singhal Aspex Management (HK) Limited 2022–2025
Ying Chen Aspex Management (HK) Limited 2023–present
Steven Liu Aspex Management (HK) Limited 2023–present
Kecheng Yin Aspex Management (HK) Limited 2019–2022
Yao-Yuan Hsu Aspex Management (HK) Limited 2025–present
Haiwen Cheng Aspex Management (HK) Limited 2025–present

Related